Skip to main content
Springer logoLink to Springer
. 2023 Dec 9;19(1):125. doi: 10.1007/s11523-023-01020-1

Correction to: EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non‑Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast

Xiuning Le 1,, Eric Nadler 2, Daniel B Costa 3, John Victor Heymach 1
PMCID: PMC10830660  PMID: 38070005

Correction to: Targeted Oncology (2023) 18:807–817 10.1007/s11523-023-00994-2

An Acknowledgment statement was added to this publication:

Acknowledgements

Some of the research described in this review was funded in part through National Institutes of Health (NIH)/National Cancer Institute (NCI) grant R37 CA218707 (to DB Costa).


Articles from Targeted Oncology are provided here courtesy of Springer

RESOURCES